Tech Company Financing Transactions

Oriel Therapeutics Funding Round

On 12/31/2008, Oriel Therapeutics raised $15 million in funding from CHL Medical Partners, HealthCare Ventures, Thomas and McNerny & Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

Post Office Box 14087
Research Triangle Park, NC 27709
USA

Phone

(919) 313-1290

Website

www.orieltherapeutics.com

Email Address

[email protected]

Overview

Oriel Therapeutics is a leading respiratory drug delivery and development company serving the pharmaceutical, biotechnology, and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and COPD.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Richard Fuller

        

President

Paul Atkins

        

VP - Regulatory Affairs

JOHN MORGAN

        

Browse more venture capital transactions:

Prev: 12/31/2008: Infrastruct Security venture capital transaction
Next: 12/31/2008: Revascular Therapeutics venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary